Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Colon Cancer|Rectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Breast Cancer|Breast Neoplasms
Interventions: DRUG: hMN14 (labetuzumab)
Sponsor: Gilead Sciences